Dr Peter Sahota was invited to present AVATR and the Inavya-InCor scientific approach to digital health experts at the SOCESP forum in São Paulo.

This presentation highlighted Inavya’s quality of the work done in partnership with the medical teams in Brazil, and supported by the British embassy.

AVATR was showcased by Guilherme Rabello, Innovation director at InCor Hospital, in a panel session for Hospitalar – one of the largest health care conventions in Brazil.

AVATR had its first peer reviewed publication in the Journal of Hypertension. The publication reported that AVATR “improves BP (Blood Pressure) control and adherence to antihypertensive medication and healthy lifestyle, providing a strong interaction between patients and healthcare team by distance monitoring”.

The study was conducted by InCor hospital in São Paulo, a global center of clinical excellence and one of the largest cardiac hospitals worldwide.

Inavya Ventures, The Zerbini foundation and Hospital das Clinicas in Brazil, have announced a partnership, combining their efforts to enrich AVATR-enabled digital healthcare to support patients across Brazil.

One of the three largest cardiological centres in the world in terms of volume of care and number of sub-specialities of cardiology, InCor is also considered the best cardiology hospital in Brazil and Latin America.

AVATR was featured in the Raconteur Special Report for the Time. The article highlighted the opportunities of international expansion and how digital business enables the development of smart cities, citing AVATR as an example.

Inavya and Imperial College NHS have just been awarded an Innovate UK R&D grant for Project BAMBOOS (Black Asian Minority Bespoke Outpatient Obesity Services).

Project BAMBOOS aims to develop highly personalised, contextual and culturally-sensitive outpatient services for patients at risk of CHD, diabetes and COVID-related complications. This is a significant step in AVATR’s mission to deliver personalised and culturally competent healthcare using AI.

HealthcareUK (part of Department of Health and Social Care and Department for International Trade) confirmed that AVATR will be officially announced as part of the 'First 100' UK Homegrown Digital Health firms.

As a result, AVATR will be presented in a slide deck for Government use only. Moreover, commercial officers from the Department for International Trade worldwide will promote AVATR via the embassy networks, with a view to encouraging international growth.

Inavya engineers and designers are now working collaboratively with St. Bartholomew's Hospital clinicians to co-develop AVATR services to support the rehabilitation of South Asian cardiac patients. The ultimate objective is to engage patients as partners in their healthcare.

This is a very exciting opportunity within the NHS that builds on AVATR AI capability to deliver highly personalised and contextualised healthcare in the community, in collaboration with Queen Mary University of London.

As part of our medical study in Brazil, AVATR has been deployed at São Paulo University Hospital InCor, for patients suffering from Hypertension. In the context of COVID this will reduce the burden on the medical team, who will be monitoring of the patients remotely. It will also allow them to update their patient care plan and protocols without bringing them to the hospital, reducing the risk of spreading COVID-19.

AVATR and Inavya Ventures Ltd. are now officially approved suppliers of healthcare technology to the UK Government.

This will help fast track our sale cycle in the UK on the back of the current studies initiated with our UK hospital partners.

Our first randomised medial trial is starting in the UK, focusing on patients suffering from obesity and atrial fibrillation. The patient onboarding phase has started. The study aims to demonstrate that the patient engagement provided through AVATR will help reduce health risks and improve the quality of life, freeing up time and resources for the medical teams.

Inavya Ventures and its AVATR technology have been shortlisted by SWITCH (Singapore Week of Innovation and Technology) as one of the top 10 startups helping to combat the current global pandemic. This is recognition of the impact our technology delivers for populations at risk and suffering from chronic disease – namely through remote monitoring and a macro dashboard for global analysis within large cities.

AVATR was awarded the prestigious European Commission Seal of Excellence, based on the quality of the technology. With this accreditation, Inavya is well-positioned to receive fresh opportunities for AVATR. In fact, and despite challenges related to the COVID-19 pandemic, we have continued development with direct engagement of clinical teams globally.

AVATR has been selected by the Barclays Eagle Labs Accelerator, among a selected number of startups with high growth potential to join the Scale-up UK programme at the University of Cambridge’s Judge Business School.

The 6-month programme aims to enhance the performance and competitiveness of high-potential, early-stage businesses with an appetite for growth and the potential to contribute to the UK economy.

The programme is designed to support the companies by helping them formulate, articulate and implement a growth plan for their business. This includes defining and articulating the business value proposition, designing a sustainable business model, enhancing operational and leadership capabilities and strengthening financial literacy.

Aymeric Teulon, Director of Inavya, has been invited to present Avatr this week at a major international health conference: Arab Health 2020.

After four years of technical development of Avatr as an AI-enabled personalised health companion to support patients and doctors, Avatr is ready to enter the market. With the MENA region witnessing a phase of significant growth, Avatr is attracting significant interest from a range of key stakeholders in Qatar, Saudi Arabia, Bahrain and the UAE.

A recent Fitch Solutions analysis reported that the MENA region’s healthcare market is projected to grow from US$ 185.5 billion in 2019 to US$ 243.6 billion in 2023. Aymeric is due to meet a range of healthcare and government stakeholders from throughout the MENA region, with the aim to support their needs with Avatr.

Dr Jaspal Peter Sahota, an Inavya scientist, has been invited to join Lord Prior (NHS England Chairman) on a select Artificial Intelligence and Smart Diagnostics Mission to India, which will take place in New Delhi, Bengaluru and Mumbai from December 9th-13th.

India's healthcare market is anticipated to grow to USD 372bn by 2022, and innovation in healthcare delivery is a key priority for healthcare providers in the country. The UK is known for innovation and expertise in both AI and healthcare, making this the perfect opportunity to showcase the best of British AI solutions.

During the Mission, Dr Sahota - who speaks Hindi, Panjabhi and Sanskrit; and who is part of the AVATR AI technology development team - will showcase AVATR technology at a number of focused events. He will also meet with key stakeholders and influencers from the Indian healthcare industry, and meet clinicians from leading hospitals interested in deploying AVATR.

AVATR has been selected as a Global Top-50 Startup by Qatar, and has been invited to profile AVATR technology at Smart Cities Expo - Doha 2019, which starts on the 29th Oct 2019.

The international conference provides a unique opportunity for entrepreneurs, investors, innovators and professionals to achieve their ambitions, learn from the best about digital entrepreneurship, network, gain inspiration to grow their business and lead the change. Commenting on this award, Dr Michael Wilkinson said “We are delighted to be selected in the Global Top-50. This opportunity to join international startups, to network and to showcase AVATR is an important opportunity as we enter the global marketplace.”

Aymeric Teulon, Director of Inavya, received the prestigious 'Made in Dauphine' award for AVATR at an event held in Paris on 10th Oct.

Paris-Dauphine University, Dauphine Alumni, and the student and alumni association, select the "Made in Dauphine" award based on innovation excellence. Commenting on receiving the award, Aymeric noted that “The selection panel really liked AVATR. Other winners of awards were Frichti (which just raised €45m), and Madbox games (just hit over 10m downloads of their gaming platform), so AVATR is in very good company.”

The selection panel included: Yannick Bollore (CEO Havas), Bertrand Cizeau (BNP Paribas Group Head of Brand, Communications and Quality), Quentin Sannie (CEO Devialet), Pierre Chassagne (EY Partner).

Following an open competition, Inavya has been selected by the Korea Institute of Startup & Entrepreneurship Development, the Enterprise Europe Network, and the Knowledge Transfer Network as one of three promising UK Tech Startups to join the K-Ground 2019 Global Startup Exchange & Collaboration Programme.

South Korea is one of the world’s most technologically advanced and digitally connected countries. Home to global giants such as Samsung, LG, Hyundai and SK Telecom - and with major government investment in key technology areas - South Korea offers unrivalled opportunities for digital Tech Startups.

During the programme, Dr Michael Wilkinson will be immersed in the South Korean Startup ecosystem, have the opportunity to meet major companies, pitch to investors and connect with South Korean and international collaborators. The 10 Day programme will centre in Pangyo, the Silicon Valley of South Korea, from 23 September to 2nd October.

LONDON:  Deeptech Angels has selected AVATR as one of four deep technology startups to present at a pitch event on Monday 8th of July.  The event is hosted exclusively at The National Liberal Club in central London, where Dr Michael Wilkinson will pitch AVATR technology in front of validated angel investors.

PARIS: AVATR has been shortlisted for the prestigious innovation award ‘MadeInDauphine’ event at Paris Dauphine University, also on Monday 8th of July. The award recognises achievement by former alumni in innovative companies with a social impact. Members of the jury include the CEOs of Havas and Devialet, the Marketing head of Dior Couture, and the head of Unilever Africa.   Paris Dauphine Universityalumnus, Aymeric Teulon, will represent AVATR.